Navigation Links
NTU and Sembcorp to jointly explore novel waste water treatment technology
Date:6/24/2009

Nanyang Technological University's Nanyang Environment and Water Research Institute (NTU-NEWRI) and Sembcorp Industries (Sembcorp) signed an agreement today to jointly explore the application of a new system for the treatment of complex industrial wastewater.

Under the agreement, Sembcorp and NTU-NEWRI will work together over the next three years to explore a novel treatment technology aimed at removing recalcitrant organic matter from wastewater. These recalcitrant organic substances are characterised by poor biodegradability and by their difficulty of removal though the biological wastewater treatment process. The project would be supervised by researchers from NTU-NEWRI as well as water experts from Sembcorp. Intellectual property rights would be jointly shared by Sembcorp and NTU-NEWRI and Sembcorp will invest an estimated $1 million in the project.

The agreement was signed at Singapore International Water Week (SIWW) 2009 by Mr Tan Cheng Guan, Sembcorp Industries' Executive Vice President for Group Business & Strategic Development and Head for Water, Energy and Middle East & North Africa, as well as Prof Ng Wun Jern, Executive Director of NTU-NEWRI. The signing was also witnessed by the Economic Development Board's Director for Cleantech Goh Chee Kiong as well as Sembcorp Group President & CEO Tang Kin Fei. This agreement follows from an umbrella Master Research Collaboration Agreement formed between Sembcorp and NTU-NEWRI at last year's SIWW.

Commenting on the collaboration, Sembcorp Group President & CEO Mr Tang Kin Fei said, "We are happy to take our R&D collaboration with NTU-NEWRI a step further with this joint testbed for new wastewater treatment technology. This underscores Sembcorp's commitment to applying best available technology to meet our customers' water and wastewater treatment needs."

Elaborating on the technology to be explored, NTU's Associate Professor Volodymyr Ivanov, the Principal Investigator who leads the NTU team for the research collaboration, said, "NTU team has developed an innovative patented process, which is well suited for the treatment of industrial wastewater. This process models nature's way of cleaning the water. It is likely that this technology can be more competitive than other technologies. We are happy to collaborate with Sembcorp and develop this testbed and explore the technology further."

Remarking on the project, Professor Ng Wun Jern, Executive Director of NTU-NEWRI said. "Launched in 2008, NEWRI provides a clearly defined window through which industry and research partners can access NTU's comprehensive EWT capabilities. This partnership with Sembcorp is a good demonstration of NEWRI's goal of translating cutting-edge new water technology research and bringing it to an industry eager to benefit society and lead in an expanding market."


'/>"/>

Contact: Esther Ang
estherang@ntu.edu.sg
656-790-6804
Nanyang Technological University
Source:Eurekalert

Related medicine news :

1. PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File
2. Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd.
3. 3rd Annual Conference on Pain Jointly Sponsored By Rehabilitation Institute of Chicago and MediCom Worldwide, Inc.
4. XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market
5. U.S. Preventive Medicine(R), The Mount Sinai Medical Center Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services
6. Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
7. U.S. Preventive Medicine(R), ParkwayHealth Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services in Asia
8. Sisters of Charity Health System & University Hospitals Announce New Agreement for Jointly Owned Hospitals
9. ASH and EHA jointly announce translational research training in hematology program
10. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
11. New research explores newborn in-hospital weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology: